在糖尿病视网膜病变的小鼠模型中,Nox4上调对PECAM-1表达的影响
Jinli Wang1, Daniel A Lai1, Joshua J Wang1
1Department of Ophthalmology and Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.
PloS one
|May 15, 2024
概括
这项研究研究了NADPH氧化酶4 (Nox4) 在调节糖尿病视网膜病变中的血小板内皮细胞粘附分子1 (PECAM-1) 表达中的作用. 研究结果表明Nox4不会显著改变视网膜内皮细胞中的PECAM-1水平.
科学领域:
- 眼科医生 眼科 眼科
- 血管生物学 血管生物学
- 分子医学是分子医学.
背景情况:
- 糖尿病视网膜病变 (DR) 导致视力丧失,由血管变化驱动.
- NADPH氧化酶4 (Nox4) 活性与DR病原发生有关,特别是血管泄漏.
- 血小板内皮细胞粘附分子1 (PECAM-1) 影响内皮屏障功能.
研究的目的:
- 为了确定Nox4上调是否影响糖尿病患者视网膜中的PECAM-1表达.
- 研究Nox4对小鼠视网膜和大脑微血管内皮细胞 (BMECs) 中PECAM-1的影响.
主要方法:
- 使用内皮细胞特异的Nox4转基因 (TG) 和条件淘汰 (cKO) 鼠标.
- 在视网膜,BMEC和培养的人类视网膜内皮细胞 (HREC) 中检查了PECAM-1mRNA和蛋白质表达.
- 在HREC中使用了腺病毒介导的Nox4过度表达.
主要成果:
- Nox4过度表达增加了PECAM-1mRNA,但不是视网膜,BMEC和HREC中的蛋白质.
- 不管糖尿病,来自Nox4 cKO小鼠的BMEC中,PECAM-1 mRNA和蛋白质水平保持不变.
- 这些结果不支持Nox4在调节糖尿病患者视网膜PECAM-1表达中的作用.
结论:
- 诺克斯4似乎没有显著调节内皮细胞或糖尿病视网膜中的PECAM-1表达.
- 在DR中Nox4诱导的血管泄漏背后的机制需要进一步研究,重点关注其他内皮结节蛋白.
相关概念视频
Cell Specific Gene Expression
13.4K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K
Diabetic Retinopathy
65
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
65


